The market for cosmetic operations without incisions or surgical intervention is referred to as the non-invasive aesthetic treatment market. These operations include cosmetic procedures including microdermabrasion, dermal fillers, laser hair removal, and Botox injections. Due to the rising need for safe, efficient, and cost-effective cosmetic treatments as well as the rising acceptance of minimally invasive procedures, the market for non-invasive aesthetic treatments is anticipated to expand in the next years. Allergan, Galderma, Merz Pharma, and Syneron Candela are a few of the market’s prominent participants.
In-depth information on the key elements accelerating market trends for non-invasive aesthetic treatments and boosting sales globally is provided by a research. The market’s competitive environment is also thoroughly analysed in the study, with key competitors highlighted and the impact of their expansion strategies assessed.
Download Free Sample Copy of this Report – https://www.factmr.com/connectus/sample?flag=S&rep_id=7162
Market Segments Covered in Non-Invasive Aesthetic Treatment Market Analysis
- By Procedure :
- Injectables
- Botulinum Toxin
- Calcium Hydroxylapatite
- Hyaluronic Acid
- Polymer Filler
- Collagen
- Skin Rejuvenation
- Chemical Peel
- Laser Skin Resurfacing
- Photorejuvenation
- Others
- Hair Removal
- Nonsurgical Fat Reduction
- Sclerotherapy
- Cellulite Treatment
- Injectables
- By End Use :
- Hospital/Surgery Center
- MedSpa
- Traditional Spa
- HCP owned clinic
Key Players
- Hologic, Inc.
- Allergan, Inc.
- Galderma S.A.
- Alma Lasers
- Syneron Candela
- Johnson & Johnson
- MerzPharma
- Lumenis
- Solta Medical
- Cutera Inc.
- Revance Therapeutics Inc.
Key Drivers and Restraints of Global Non-invasive Aesthetic Treatment Market
- Increase in geriatric population, rise in adoption of non-invasive aesthetic treatment, and surge in beauty consciousness among consumers are the major drivers of the global non-invasive aesthetic treatment market
- According to the American Society of Plastic Surgeons, the number of invasive cosmetic procedures dropped 6% from 2000 to 2016 in the U.S., while non-invasive and minimally invasive procedures witnessed 180% increase during that same period
- Availability of technologically advanced & user-friendly products and increase in demand for aesthetic treatments among men are the key factors fueling the growth of the global non-invasive aesthetic treatment market
- Moreover, increase in the number of approved products and high efficiency & safety offered by some products boost the growth of the global non-invasive aesthetic treatment market
Competitive Landscape
Companies operational in Non-Invasive Treatment Market compete on the basis of innovation of their products, quality, brand reputation, and market presence to sell their products through various industries. Companies are employing a variety of strategies to remain competitive.
- In 2020, Alma introduced a new platform which was hybrid and focused on investigation of several options like ablative, non-ablative, and the thermal therapies on skin rejuvenation and scar revision, also the synergistic effects. Due to this, the availability of user-friendly and technologically improved non-invasive aesthetic solutions is increasing, hence fueling the market
- In 2021, Candela launched the Fax Pro system, which was a non-ablative functional device. It was also approved by FDA and marked by CE. The system was the first one that offered dual depth skin resurfacing. With the help of two applicators, it could perform dual depth skin resurfacing, promoting new collagen showing smoother and brighter skin.
- In 2021, Lumenis, sold their surgical division to Boston scientific corporation. The reason was they wanted to invest that amount to increase the growth of aesthetic and vision businesses by focusing on R&D, worldwide sales and developing marketing channels.
Key Companies Profiled
- Hologic, Inc.
- Allergan, Inc.
- Galderma S.A.
- Alma Lasers
- Syneron Candela
- Johnson & Johnson
- MerzPharma
- Lumenis
- Solta Medical
- Cutera Inc.
- Revance Therapeutics Inc.
Why choose Fact.MR?
We carry immense pride in saying that our work is recognized by 150+ countries worldwide. Our experience is conveyed by the fact that we have published 6, 000+ reports, thanks to our dedicated team of professionals. With digital intelligence solutions, we support our clients in remaining at the driver’s seat. Our crew of 300+ analysts are available 24/7 to offer dynamic updates regarding various verticals and companies.
